Nell'ambito del ciclo di webinars "I pomeriggi dell'Immunologia", organizzati e promossi dalla Rete degli Immunologi del CNR con il patrocinio del Dipartimento di Scienze Biomediche del CNR

Martedì, 15 giugno, 2021 ore 16:00
Rudolf Valenta
Medical University of Vienna, Austria
"From molecular immunotherapy of allergy towards prophylactic allergy vaccination"

Modera Paolo Colombo, Istituto per la Ricerca e l'Innovazione Biomedica - CNR, Palermo

Per partecipare al webinar si prega di registrarsi al seguente link:
https://attendee.gotowebinar.com/register/6864528583133842959

Rudolf Valenta is Professor for Allergology at the Medical University of Vienna. He was among the first to elucidate the molecular structures of the disease-causing allergens by molecular cloning. He then focused his research on the development of diagnostic and therapeutic strategies for allergic patients, demonstrating that recombinant allergens can be used for molecular allergy diagnosis, a work which has initiated a paradigm shift in allergy towards personalized medicine. This discovery introduces preventive medical examination in early childhood as a basis for allergy prevention. Based on the knowledge of the disease-eliciting allergen molecules, Rudolf Valenta developed new forms of molecular allergy vaccines for the treatment of allergic patients and was the first to demonstrate that molecular vaccines are effective for therapeutic approaches. He currently works on prophylactic vaccination against allergy.
Rudolf Valenta's work is highly cited, he has been awarded several prestigious national and international awards, among them the START Award of the FWF, the International Pharmacia Award and the Sarstedt Award.